BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27285276)

  • 1. 2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.
    Garg S; Raghav N
    Bioorg Chem; 2016 Aug; 67():64-74. PubMed ID: 27285276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.
    Raghav N; Jangra S; Kumar A; Bhattacharyya S
    Int J Biol Macromol; 2017 Jan; 94(Pt A):719-727. PubMed ID: 27780761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.
    Raghav N; Singh M
    Bioorg Chem; 2017 Dec; 75():38-49. PubMed ID: 28915464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3-Dihydroquinazolin-4(1H)-one derivatives as potential non-peptidyl inhibitors of cathepsins B and H.
    Singh M; Raghav N
    Bioorg Chem; 2015 Apr; 59():12-22. PubMed ID: 25665518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl hydrazides and triazoles as novel inhibitors of mammalian cathepsin B and cathepsin H.
    Raghav N; Singh M
    Eur J Med Chem; 2014 Apr; 77():231-42. PubMed ID: 24642566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some thiocarbamoyl based novel anticathepsin agents.
    Kaur R; Raghav N
    Bioorg Chem; 2020 Nov; 104():104174. PubMed ID: 32932119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-formylpyrazolines and N-benzoylpyrazolines as novel inhibitors of mammalian cathepsin B and cathepsin H.
    Raghav N; Garg S
    Bioorg Chem; 2014 Dec; 57():43-50. PubMed ID: 25181676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.
    Raghav N; Singh M
    Bioorg Med Chem; 2014 Aug; 22(15):4233-45. PubMed ID: 24913985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAR studies of o-hydroxychalcones and their cyclized analogs and study them as novel inhibitors of cathepsin B and cathepsin H.
    Raghav N; Garg S
    Eur J Pharm Sci; 2014 Aug; 60():55-63. PubMed ID: 24780403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and docking studies of bischalcones based quinazoline-2(1H)-ones and quinazoline-2(1H)-thiones derivatives as novel inhibitors of cathepsin B and cathepsin H.
    Raghav N; Singh M
    Eur J Pharm Sci; 2014 Apr; 54():28-39. PubMed ID: 24412851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B.
    Mendieta L; Picó A; Tarragó T; Teixidó M; Castillo M; Rafecas L; Moyano A; Giralt E
    ChemMedChem; 2010 Sep; 5(9):1556-67. PubMed ID: 20652927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keto-1,3,4-oxadiazoles as cathepsin K inhibitors.
    Palmer JT; Hirschbein BL; Cheung H; McCarter J; Janc JW; Yu ZW; Wesolowski G
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2909-14. PubMed ID: 16546382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose.
    Jung M; Lee J; Seo HY; Lim JS; Kim EK
    PLoS One; 2015; 10(1):e0116972. PubMed ID: 25625842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule inhibitors of cathepsin L incorporating functionalized ring-fused molecular frameworks.
    Song J; Jones LM; Chavarria GE; Charlton-Sevcik AK; Jantz A; Johansen A; Bayeh L; Soeung V; Snyder LK; Lade SD; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2013 May; 23(9):2801-7. PubMed ID: 23540644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
    Azaryan AV; Hook VY
    Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds.
    Mirković B; Renko M; Turk S; Sosič I; Jevnikar Z; Obermajer N; Turk D; Gobec S; Kos J
    ChemMedChem; 2011 Aug; 6(8):1351-6. PubMed ID: 21598397
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors.
    Baek KH; Karki R; Lee ES; Na Y; Kwon Y
    Bioorg Chem; 2013 Dec; 51():24-30. PubMed ID: 24095934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chalcones, semicarbazones and pyrazolines as inhibitors of cathepsins B, H and L.
    Raghav N; Kaur R
    Int J Biol Macromol; 2015 Sep; 80():710-24. PubMed ID: 26193682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
    Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.